Kaynakça
Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol 2006;2:425-33.
Calgüneri M, Oztürk MA, Ozbalkan Z, et al. Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus. J Int Med Res 2003;31:345-9.
Motulsky AG, Weinberg S, Saphir O, Rosenberg E. Lymph nodes in rheumatoid arthritis. AMA Arch Intern Med 1952;90:660-76.
Cruickshank B. Lesions of lymph nodes in rheumatoid disease and in disseminated lupus erythematosus. Scott Med J 1958;3:110-9.
Nosanchuk JS, Schnitzer B. Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study. Cancer 1969;24:243-54.
Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scan J Rheumatol 2006;35:169-74.
Ekström K, Hjalgrim H, Brandt L, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003;48:963-70.
Hoshida Y, Tomita Y, Zhiming D, et al. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 2004;108:443-9.
Wolfe F, Fries JF. Role of death due to leukemia/lymphoma in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:2694-5.
Baecklund E, Sundström C, Ekbom A, et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003;48:1543-50.
Mariette X, Cazals-Hatem D, Warszawki J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 2002;99:3909-15.
Ohosone Y, Okano Y, Kameda H, et al. Clinical characteristics related to methotrexate-induced pancytopenia. Clin Rheumatol 1997;16:321-3.
Feng WH, Cohen JI, Fischer S, et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 2004;96:1691-702.
Ebeo CT, Girish MR, Byrd RP, Roy TM, Mehta JB. Methotrexate-induced pulmonary lymphoma. Chest 2003;123:2150-3.
